Abbott Labs (ABT) PT Raised to $141 at Barclays
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $111.59 -2.2%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 1 | New: 0
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 1 | New: 0
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Abbott Labs (NYSE: ABT) to $141.00 (from $133.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Abbott wins FDA clearance for dual glucose-ketone diabetes sensor
- Citi Upgrades Bapcor Ltd. (BAP:AU) to Neutral
- Citi Upgrades Ming Yuan Cloud Group Holdings Ltd (909:HK) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
